Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05722873 · University of Pittsburgh

The Metabolic Effects of Intermittent Fasting

What this study is about

Caloric restriction has beneficial metabolic effects in humans including weight loss and improvement in blood pressure and lipid levels. Intermittent fasting has emerged as a popular alternative to caloric restriction as it does not require daily adherence to a dietary protocol, but whether the benefits of fasting protocols are dependent on weight loss is not known.

View original scientific description

Caloric restriction has beneficial metabolic effects in humans including weight loss and improvement in blood pressure and lipid levels. Intermittent fasting has emerged as a popular alternative to caloric restriction as it does not require daily adherence to a dietary protocol, but whether the benefits of fasting protocols are dependent on weight loss is not known. In this study, the investigators will explore the metabolic effects of fasting and evaluate whether these effects, including negative effects on bone metabolism, are independent of weight loss.

Interventions

BEHAVIORAL

Fasting arm

Study participants will fast one day per week for 12 weeks

BEHAVIORAL

Weight maintenance

Study participants will be counseled to maintain body weight

BEHAVIORAL

Counseling

Study participants will be counseled on optimal diet and activity recommendations for maintaining/achieving a normal BMI

Primary outcome measures

Triglyceride carbon content and degree of saturation

Time frame: Baseline, 3 months

Change in triglyceride carbon content and degree of saturation (% variation explained by both carbon number and double bond number in a regression model) between Baseline and Final Intervention visits

Trabecular bone microarchitecture

Time frame: Baseline, 3 months

Change in trabecular bone volume fraction at the radius between Baseline and Final Intervention visits

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Men and women, ages 21-45 years
  • BMI of at least 21 kg/m2 and up to and including BMI of 29 kg/m2
  • Normal thyroid function
  • Regular menses (women)
  • At least one first-degree relative with type 2 diabetes (T2D) and/or history of gestational diabetes

Exclusion criteria

  • Any chronic diseases including hypertension and Type 2 diabetes mellitus
  • Indication for lipid-lowering therapy in non-diabetics, using the more stringent AHA guideline cutoff (LDL\>190 or an estimated 10-year ASCVD risk of \>7.5%)
  • Chronic medications, including oral contraceptive pills
  • Pregnant and/or breastfeeding
  • History of an eating disorder
  • 25-OH vitamin D level \< 20 ng/mL
  • Active substance abuse, including alcohol
  • Subjects with a prior history of intermittent fasting
  • The study physician feels that the subject may not be able to safely complete the protocol or may place themselves at risk by undergoing the protocol

Where

  • Pittsburgh, Pennsylvania

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related conditions & keywords

Normal and Overweight Individuals at High-risk of Diabetes

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced May 18, 2026 · Source of record for eligibility and locations

📊
1 of 90 participants interested
1% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Pittsburgh

Pennsylvania

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More ALS Trials by City

Browse all als clinical trials in these cities — not just this study.

Looking for Normal and Overweight Individuals at High-risk of Diabetes Treatment in Pittsburgh?

Join others in Pennsylvania exploring innovative treatment options through clinical research

Normal and Overweight Individuals at High-risk of Diabetes Treatment Options in Pittsburgh, Pennsylvania

If you're searching for Normal and Overweight Individuals at High-risk of Diabetes treatment in Pittsburgh, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Pittsburgh and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Normal and Overweight Individuals at High-risk of Diabetes. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Pennsylvania
Now Enrolling
Up to 90 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Normal and Overweight Individuals at High-risk of Diabetes?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Normal and Overweight Individuals at High-risk of Diabetes

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Normal and Overweight Individuals at High-risk of Diabetes Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05722873. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.